Sint Antonius Ziekenhuis Stichting — Sponsor Intelligence | 7 EU Trials

Filter these 7 trials by condition, phase, country and more.

7 Registered trials

6 Recruiting

1 Completed trials

1 Countries active

14 Unique IMPs

100% Results reported

Phase II

Phase IV

100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

Top IMPs

7 total

Platelet inhibition versus direct oral anticoagulation in patients undergoing percutaneous closure of patent foramen ovale or atrial septal … Recruiting

2024-517115-70-00 Phase II 1 country CLOPIDOGREL; RIVAROXABAN
The dosage of antithrombotics adjusted to body weight Recruiting

2024-518890-33-00 Phase IV 1 country CLOPIDOGREL; PRASUGREL
Local Levobupivacaine for pain reflief after esophageal ESD Recruiting

2024-510912-66-00 Phase IV 1 country DICLOFENAC SODIUM; LEVOBUPIVACAINE HYDROCHLORIDE; PARACETAMOL
Remimazolam versus Midazolam for sedation during upper GI endoscopy: a randomized controlled trial Recruiting

2024-516432-94-00 Phase IV 1 country MIDAZOLAM; REMIMAZOLAM
POPular GUILTY PILOT: Genotype-guided Clopidogrel monotherapy Recruiting

2024-518464-12-00 Phase IV 1 country ACETYLSALICYLIC ACID; CLOPIDOGREL
Intravenous iron to treat postoperative anaemia in older cardiac surgery patients: a randomized controlled trial (AGE ANAEMIA study) Recruiting

2024-515920-35-01 Phase IV 1 country FERRIC DERISOMALTOSE; SODIUM CHLORIDE
Phenosar Ended

2024-513534-38-00 Phase IV 1 country AZITHROMYCIN; DOXYCYCLINE

Showing 1–7 of 7 trials